While STAT3 inhibits antigen presentation and promotes the tolerogenic effects of myeloid cells, it is also required for the expansion of cytotoxic CD8 T cells in cancer patients and for the development and maintenance of memory T cells (22, 23). The gene discussed is CD8A; the disease is cancer.